Stock Analiz

Eupraxia Pharmaceuticals Inc. (EPRX) stock forecast and price target

Price $8.15 · data as of November 13, 2026

12-month price target

Average target$16.71
Upside / downside+105.0%
Analysts12
ConsensusStrong buy
Low $14.00Average $16.71High $25.00

Gold marker: average target · white marker: today’s price ($8.15)

Analyst ratings

Strong buy 1Buy 12Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.96+6.8%$0
Next fiscal year
ends December 31, 2027
$-1.04−7.9%$712580
Next quarter
ends December 31, 2026
$-0.26+30.6%$0
Quarter after
ends December 31, 2026
$-0.26+29.2%$0

Consensus of the analysts covering Eupraxia Pharmaceuticals, updated daily. In the last 30 days 1 estimates were raised and 1 lowered.

Frequently asked questions

What is the Eupraxia Pharmaceuticals stock price target?

The average 12-month target from 12 analysts is $16.71, 105.0% above the current price of $8.15 Targets range from $14.00 to $25.00.

Is Eupraxia Pharmaceuticals a buy according to analysts?

The consensus rating is “Strong buy” (1 strong buy, 12 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Eupraxia Pharmaceuticals expected to earn?

Analysts expect EPS of $-0.96 for the fiscal year ending December 31, 2026 and $-1.04 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.